ORADIN PHARMACEUTICAL LTD.

Follow

Organization

Tel Aviv, IL

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Adenosine A3 receptor antagonists for treating aging skin and wounds
- Patent number 12,233,053
- Issue date Feb 25, 2025
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana Madi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A3 adenosine receptor ligands for modulation of pigmentation
- Patent number 9,668,959
- Issue date Jun 6, 2017
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana Madi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A3 adenosine receptor ligands for modulation of pigmentation
- Patent number 9,199,102
- Issue date Dec 1, 2015
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana Madi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ADENOSINE A3 RECEPTOR ANTAGONISTS FOR TREATING AGING SKIN AND WOUNDS
- Publication number 20240216351
- Publication date Jul 4, 2024
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana MADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION
- Publication number 20160136079
- Publication date May 19, 2016
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana MADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION
- Publication number 20120134945
- Publication date May 31, 2012
- ORADIN PHARMACEUTICAL LTD.
- Lea Levana Madi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks